Pharmas hesitated in developing generics, showing decrease in bioequivalently-tested drugs

It was observed there were only 96 pharmaceutical products approved through bioequivalence test this year. This is because pharmaceutical companies are hesitated in developing generic products.

According to the Ministry of Food and Drug Safety(MFDS), the collective number of pharmaceutical products which passed bioequivalence test so far was 10,758 products, including the 96 products approved ...